Johnson & Johnson to Participate in the… Leave a comment

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference | Johnson & Johnson<![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[<![CDATA[]]]]]]>]]]]>]]><![CDATA[<![CDATA[]]]]>]]><!–[if lte IE 9 Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Latest News

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

New Brunswick, NJ (August 2nd, 2022) — Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

###

• Press Contacts:
  Rachel Hooper
  rhooper@its.jnj.com

  Investor Contacts:
  Sarah Wood
  (732) 524-2617

This site uses cookies as described in our Cookie Policy. Please click the “Accept” button or continue to use our site if you agree to our use of cookies.

Reject Accept

<![CDATA[<![CDATA[<![CDATA[]]]]]]>]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]><![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]> <![CDATA[<![CDATA[]]]]>]]>

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.

Source